Bibliographic Details
| Title: |
Artificial Intelligence–Powered Assessment of Pathologic Response to Neoadjuvant Atezolizumab in Patients With NSCLC: Results From the LCMC3 Study |
| Authors: |
Dacic, Sanja, Travis, William D., Giltnane, Jennifer M., Kos, Filip, Abel, John, Hilz, Stephanie, Fujimoto, Junya, Sholl, Lynette, Ritter, Jon, Khalil, Farah, Liu, Yi, Taylor-Weiner, Amaro, Resnick, Murray, Yu, Hui, Hirsch, Fred R., Bunn, Paul A., Jr., Carbone, David P., Rusch, Valerie, Kwiatkowski, David J., Johnson, Bruce E., Lee, Jay M., Hennek, Stephanie R., Wapinski, Ilan, Nicholas, Alan, Johnson, Ann, Schulze, Katja, Kris, Mark G., Wistuba, Ignacio I. |
| Source: |
In Journal of Thoracic Oncology May 2024 19(5):719-731 |
| Database: |
ScienceDirect |
